These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 12783070

  • 1. Effects of ACE-inhibitors and beta-blockers on left ventricular remodeling in chronic heart failure.
    Khattar RS.
    Minerva Cardioangiol; 2003 Apr; 51(2):143-54. PubMed ID: 12783070
    [Abstract] [Full Text] [Related]

  • 2. Mechanistic and clinical rationales for using beta-blockers in heart failure.
    Bristow MR.
    J Card Fail; 2000 Jun; 6(2 Suppl 1):8-14. PubMed ID: 10908093
    [Abstract] [Full Text] [Related]

  • 3. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
    Khattar RS, Senior R, Soman P, van der Does R, Lahiri A.
    Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 5. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L.
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [Abstract] [Full Text] [Related]

  • 6. Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction.
    Udelson JE, Konstam MA.
    J Card Fail; 2002 Dec; 8(6 Suppl):S465-71. PubMed ID: 12555159
    [Abstract] [Full Text] [Related]

  • 7. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN.
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [Abstract] [Full Text] [Related]

  • 8. beta-Blocker therapy in heart failure.
    Doughty RN.
    Heart Fail Monit; 2000 Oct; 1(1):2-7. PubMed ID: 12634875
    [Abstract] [Full Text] [Related]

  • 9. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U, Wollert KC, Drexler H.
    Cardiovasc Res; 2009 Feb 15; 81(3):519-27. PubMed ID: 19019834
    [Abstract] [Full Text] [Related]

  • 10. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M, Lutiger B, Madeira H, Thygesen K, Bobbio M, Hildebrandt P, Jaarsma W, Riegger G, Rydén L, Scherhag A, Soler-Soler J, Remme WJ, CARMEN investigators and co-ordinators.
    Eur J Heart Fail; 2004 Jun 15; 6(4):467-75. PubMed ID: 15182773
    [Abstract] [Full Text] [Related]

  • 11. Drugs for left ventricular remodeling in heart failure.
    Frigerio M, Roubina E.
    Am J Cardiol; 2005 Dec 19; 96(12A):10L-18L. PubMed ID: 16399088
    [Abstract] [Full Text] [Related]

  • 12. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M, Hara Y, Ohtsuka T, Suzuki J, Saeki H, Ogimoto A, Shigematsu Y.
    J Cardiovasc Pharmacol; 2003 Jan 19; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [Abstract] [Full Text] [Related]

  • 13. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
    Remme WJ, Riegger G, Hildebrandt P, Komajda M, Jaarsma W, Bobbio M, Soler-Soler J, Scherhag A, Lutiger B, Rydén L.
    Cardiovasc Drugs Ther; 2004 Jan 19; 18(1):57-66. PubMed ID: 15115904
    [Abstract] [Full Text] [Related]

  • 14. Strategies to attenuate pathological remodeling in heart failure.
    Eapen Z, Rogers JG.
    Curr Opin Cardiol; 2009 May 19; 24(3):223-9. PubMed ID: 19318933
    [Abstract] [Full Text] [Related]

  • 15. Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials.
    Greenberg BH.
    J Card Fail; 2002 Dec 19; 8(6 Suppl):S486-90. PubMed ID: 12555162
    [Abstract] [Full Text] [Related]

  • 16. Ventricular remodeling and its prevention in the treatment of heart failure.
    Patten RD, Udelson JE, Konstam MA.
    Curr Opin Cardiol; 1998 May 19; 13(3):162-7. PubMed ID: 9649938
    [Abstract] [Full Text] [Related]

  • 17. [New aspects of ACE inhibitor treatment of heart failure].
    Dietz R, Osterziel KJ.
    Z Kardiol; 1996 May 19; 85 Suppl 6():241-6. PubMed ID: 9064971
    [Abstract] [Full Text] [Related]

  • 18. A continued role for beta-blocker therapy in heart failure.
    Korczyk DP, Doughty RN.
    Heart Fail Monit; 2006 May 19; 5(1):15-9. PubMed ID: 16547531
    [Abstract] [Full Text] [Related]

  • 19. Contemporary medical management of left ventricular dysfunction and congestive heart failure.
    Teo KK, Ignaszewski AP, Gutierrez R, Hill KL, Martin SL, Calhoun HP, Humen DP, Montague TJ.
    Can J Cardiol; 1992 May 19; 8(6):611-9. PubMed ID: 1354569
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W.
    J Cardiovasc Electrophysiol; 2009 Apr 19; 20(4):395-400. PubMed ID: 19017351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.